Difference between revisions of "Category:ALK inhibitors"
Jump to navigation
Jump to search
(Created page with "A class of drugs that inhibit the anaplastic lymphoma kinase (ALK). The first FDA-approved drug in this class was Crizotinib (Xalkori).") |
m |
||
| (One intermediate revision by the same user not shown) | |||
| Line 1: | Line 1: | ||
| − | A class of drugs that inhibit the anaplastic lymphoma kinase (ALK). The first FDA-approved drug in this class was [[Crizotinib (Xalkori)]]. | + | A class of drugs that inhibit the [https://en.wikipedia.org/wiki/Anaplastic_lymphoma_kinase anaplastic lymphoma kinase (ALK)]. The first FDA-approved drug in this class was [[Crizotinib (Xalkori)]]. |
| + | |||
| + | [[Category:Tyrosine kinase inhibitors]] | ||
Latest revision as of 13:57, 22 January 2021
A class of drugs that inhibit the anaplastic lymphoma kinase (ALK). The first FDA-approved drug in this class was Crizotinib (Xalkori).
Pages in category "ALK inhibitors"
The following 9 pages are in this category, out of 9 total.